Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
UBS
Medtronic
Citi
Daiichi Sankyo
Mallinckrodt
Argus Health
Colorcon

Generated: May 23, 2018

DrugPatentWatch Database Preview

MYTELASE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mytelase patents expire, and what generic alternatives are available?

Mytelase is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in MYTELASE is ambenonium chloride. Additional details are available on the ambenonium chloride profile page.
Summary for MYTELASE
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 19
Patent Applications: 148
DailyMed Link:MYTELASE at DailyMed
Drug patent expirations by year for MYTELASE
Medical Subject Heading (MeSH) Categories for MYTELASE
Synonyms for MYTELASE
(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium dichloride
(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium;dichloride
(Oxalylbis(iminoethylen))bis(2-chlorbenzyl)diethylammonium chlorid)
(Oxalylbis(iminoethylene))bis((o-chlorobenzyl)diethylammonium) dichloride
115-79-7
2,2'-[(1,2-dioxoethane-1,2-diyl)diimino]bis[N-(2-chlorobenzyl)-N,N-diethylethanaminium] dichloride
2,2'-[(1,2-dioxoethane-1,2-diyl)diimino]bis{N-[(2-chlorophenyl)methyl]-N,N-diethylethanaminium} dichloride
51FOB87G3I
52022-31-8
AC1L1QO5
AI3-22370
AKOS024457845
Ambenonii chloridum
Ambenonii chloridum [INN-Latin]
Ambenonium chloride
Ambenonium chloride (JP17/INN)
Ambenonium Chloride [USAN:INN:BAN:JAN]
Ambenonium chloride [USP:INN:BAN:JAN]
Ambenonium dichloride
Ambestigmin chloride
AMMONIUM, (OXALYLBIS(IMINOETHYLENE))BIS((o-CHLOROBENZYL)DIETHYL-, DICHLORIDE
B6286
Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl-, dichloride
Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl)-, dichloride
C28H42Cl2N4O2
CAS-115-79-7
CHEBI:2628
CHEMBL1200541
Chlorure d'ambenonium
Chlorure d'ambenonium [INN-French]
Cloruro de ambenonio
Cloruro de ambenonio [INN-Spanish]
CTK8F7699
D01001
DSSTox_CID_2582
DSSTox_GSID_22582
DSSTox_RID_76642
DTXSID3022582
EINECS 204-107-5
HMS3266K15
LS-18739
Misuran
MolPort-003-666-839
Mysuran
Mytelase (TN)
mytelase dichloride
N,N inverted exclamation marka-[(1,2-Dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)] bis[2-chloro-N,N-diethylbenzene-methanaminium]
N,N'-[(1,2-Dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)]bis(2-chloro-N,N-diethylbenzenemethaminium) dichloride
N,N'-Bis(2-diethylaminoethyl)oxamid bis-2-chlorbenzyl chlorid
N,N'-Bis(2-diethylaminoethyl)oxamide bis(2-chlorobenzyl chloride)
N,N'-Oxalylbis(N-2-aminoethyl-N-2-chlorobenzyldiethylammonium) dichloride
NCGC00024567-03
NCGC00163221-01
Oksazil
OR009277
OR205937
Oxamizil
Oxazil
Oxazyl
Oxazylum
SCHEMBL133487
SR-01000597958
SR-01000597958-1
Tox21_112030
Tox21_112030_1
UNII-51FOB87G3I
Win 8077

US Patents and Regulatory Information for MYTELASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us MYTELASE ambenonium chloride TABLET;ORAL 010155-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Argus Health
Accenture
Queensland Health
Express Scripts
Chubb
Julphar
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.